| Patent Number |
Title Of Patent |
Date Issued |
| 6547997 |
Method for producing solvent-free noncrystalline biologically active substances |
April 15, 2003 |
| Solvent-free noncrystalline bioactive substances are prepared from the corresponding crystalline bioactive substances in an extruder by melting the substances in the extruder under reduced pressure and in the absence of auxiliaries, cooling and comminuting. |
| 6014577 |
Device for the detection of analyte and administration of a therapeutic substance |
January 11, 2000 |
| The present invention relates to a device for the sampling of blood or other body fluids which includes means for the direct measurement of the analyte of interest within the fluid. Also disclosed is a `closed-loop` device and method wherein the analyte is measured and the required amoun |
| 5968809 |
Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
October 19, 1999 |
| The present invention relates to fatty acid desaturases able to catalyze the conversion of oleic acid to linoleic acid, linoleic acid to gamma-linolenic acid, or of alpha-linolenic acid to stearidonic acid. Nucleic acid sequences encoding desaturases, nucleic acid sequences which hyb |
| 5908862 |
Water-miscible esters of mono--and diglycerides having antibacterial activity and their use in i |
June 1, 1999 |
| A process of treating a bacterial infection in a subject in need of such treatment including the step of administering to the subject an effective bactericidal amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacety |
| 5541320 |
Process for the preparation of a substituted diaminoalcohol |
July 30, 1996 |
| A process is disclosed for the preparation of a substituted diaminoalcohol of the formula: ##STR1## |
| 5478754 |
Determination of glycated hemoglobin by fluorescence quenching |
December 26, 1995 |
| The present invention relates to the measurement of glycated hemoglobin by fluorescence quenching. The present invention uniquely involves performing two sequential fluorescent quenching measurements: one measurement of the fluorescent quenching due to total hemoglobin in the sample and |
| 5284139 |
Hemometrix temperature compensation |
February 8, 1994 |
| A method for converting a value for the partial pressure of oxygen (pO.sub.2) in blood at a measurement temperature to a corresponding value at a reference temperature (37.degree. C.). A value for pO.sub.2 is determined by measurements made in a patient's blood stream using a phospho |
